Annual Secretarial Compliance for the financial year ended on 31-03-2026.
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indo Us Bio-Tech Limited has filed its Annual Secretarial Compliance Report for the financial year ended 31st March 2026, issued by Practising Company Secretary Amrish N. Gandhi. The report reveals several compliance gaps: the company was fined by NSE for non-compliance with Regulation 18(1) of SEBI LODR Regulations; it failed to implement or maintain a Structured Digital Database (SDD) for insider trading prevention; CSR Committee meeting minutes were not properly maintained; complete performance evaluation of the Board and Committees was not carried out; and prior Audit Committee approval was not obtained for related party transactions (only shareholder approval came later at AGM). The company has no subsidiaries and no disqualified directors.
Multiple compliance violations including an NSE fine, missing insider trading safeguards, and procedural lapses in related party transactions signal weak corporate governance, which could negatively impact investor confidence and the stock price.